Stock listing
Lang & Schwarz:A3DMC3 TME Pharma N.V. Aktie
German listing (Lang & Schwarz) of TME Pharma N.V. · home listing Euronext:ALTME
Follow TME Pharma N.V. into a list and get an email when it puts out news.
Home listing price · EURONEXT:ALTME
€0.106 EUR -0.001 (-0.9%)
Close on Nov 17, 2026 · This listing has no price on 6ix; the price shown is the home listing's, EURONEXT:ALTME
- Day range
- €0.104 – €0.107 EURNov 17, 2026
- Volume
- 835,044 sharesNov 17, 2026
- Market cap
- €10.07M EURAt the close on Nov 17, 2026 · price × 94.99M shares outstanding
- 52-week range
- €0.049 – €0.175 EURLowest and highest trades, Nov 18, 2025 – Nov 17, 2026
- Traded on an average day
- €392,697 EURMedian day 1.21M shares · last 3 months, Aug 17, 2026 – Nov 17, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:ALTME · Home | €0.106 EUR | -0.001 (-0.9%) | 835,044 | €0.107 | €0.107 | €0.104 | €0.107 | Close on Nov 17, 2026 |
| Frankfurt:0N6A | €0.103 EUR | -0.001 (-1.0%) | — | €0.103 | €0.103 | €0.102 | €0.104 | Close on Nov 17, 2026 |
Daily closes
Last 3 months, Aug 17, 2026 – Nov 17, 2026 · EURONEXT:ALTME · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €0.106 | -0.001 | -0.9% | €0.107 | €0.107 | €0.104 | 835,044 | |
| €0.107 | +0.002 | +1.5% | €0.105 | €0.108 | €0.104 | 220,335 | |
| €0.105 | -0.008 | -7.1% | €0.113 | €0.113 | €0.105 | 676,653 | |
| €0.113 | +0.007 | +6.6% | €0.106 | €0.114 | €0.105 | 775,439 | |
| €0.106 | 0.000 | 0.0% | €0.110 | €0.110 | €0.104 | 798,806 | |
| €0.106 | -0.003 | -2.9% | €0.113 | €0.118 | €0.106 | 1,203,223 | |
| €0.110 | +0.002 | +2.2% | €0.107 | €0.112 | €0.107 | 348,131 | |
| €0.107 | -0.005 | -4.3% | €0.109 | €0.113 | €0.107 | 672,990 | |
| €0.112 | +0.002 | +2.2% | €0.105 | €0.116 | €0.105 | 1,764,145 | |
| €0.110 | -0.004 | -3.9% | €0.110 | €0.113 | €0.104 | 1,646,802 | |
| €0.114 | 0.000 | -0.3% | €0.116 | €0.116 | €0.104 | 1,750,390 | |
| €0.114 | -0.010 | -7.7% | €0.126 | €0.126 | €0.106 | 3,610,518 | |
| €0.124 | -0.016 | -11.3% | €0.137 | €0.140 | €0.121 | 3,117,937 | |
| €0.140 | +0.020 | +16.5% | €0.151 | €0.171 | €0.133 | 12,986,535 | |
| €0.120 | -0.002 | -1.8% | €0.120 | €0.124 | €0.117 | 274,047 | |
| €0.122 | +0.006 | +5.0% | €0.116 | €0.130 | €0.113 | 1,282,288 | |
| €0.116 | -0.008 | -6.1% | €0.130 | €0.130 | €0.116 | 1,886,173 | |
| €0.124 | +0.014 | +12.3% | €0.113 | €0.128 | €0.110 | 2,453,669 | |
| €0.110 | -0.004 | -3.8% | €0.113 | €0.120 | €0.110 | 822,500 | |
| €0.115 | +0.009 | +8.3% | €0.109 | €0.115 | €0.106 | 572,576 | |
| €0.106 | -0.005 | -4.5% | €0.111 | €0.111 | €0.105 | 199,094 | |
| €0.111 | +0.000 | +0.2% | €0.111 | €0.111 | €0.104 | 334,966 | |
| €0.111 | +0.003 | +3.0% | €0.108 | €0.111 | €0.103 | 403,927 | |
| €0.108 | +0.002 | +1.5% | €0.102 | €0.108 | €0.100 | 710,212 | |
| €0.106 | -0.007 | -6.2% | €0.113 | €0.113 | €0.100 | 1,500,473 | |
| €0.113 | -0.001 | -0.9% | €0.120 | €0.120 | €0.113 | 445,939 | |
| €0.114 | 0.000 | 0.0% | €0.113 | €0.120 | €0.110 | 912,323 | |
| €0.114 | -0.008 | -6.6% | €0.122 | €0.122 | €0.112 | 1,189,283 | |
| €0.122 | -0.008 | -6.0% | €0.127 | €0.127 | €0.121 | 818,839 | |
| €0.130 | +0.001 | +1.1% | €0.128 | €0.140 | €0.118 | 3,824,909 | |
| €0.128 | +0.019 | +16.9% | €0.110 | €0.128 | €0.107 | 2,307,717 | |
| €0.110 | +0.007 | +6.6% | €0.106 | €0.113 | €0.103 | 1,723,071 | |
| €0.103 | 0.000 | -0.4% | €0.103 | €0.106 | €0.103 | 526,304 | |
| €0.103 | -0.001 | -0.8% | €0.104 | €0.106 | €0.103 | 220,609 | |
| €0.104 | +0.001 | +0.6% | €0.107 | €0.107 | €0.103 | 231,039 | |
| €0.104 | -0.001 | -1.1% | €0.104 | €0.107 | €0.103 | 560,113 | |
| €0.105 | 0.000 | -0.2% | €0.103 | €0.106 | €0.102 | 686,836 | |
| €0.105 | +0.002 | +1.9% | €0.113 | €0.113 | €0.104 | 514,824 | |
| €0.103 | -0.005 | -4.6% | €0.108 | €0.108 | €0.102 | 453,261 | |
| €0.108 | 0.000 | 0.0% | €0.106 | €0.110 | €0.106 | 347,736 | |
| €0.108 | -0.002 | -1.8% | €0.110 | €0.114 | €0.105 | 1,120,307 | |
| €0.110 | -0.004 | -3.5% | €0.118 | €0.120 | €0.108 | 1,017,548 | |
| €0.114 | +0.012 | +11.8% | €0.104 | €0.124 | €0.101 | 4,849,914 | |
| €0.102 | -0.003 | -2.9% | €0.103 | €0.108 | €0.100 | 2,167,171 | |
| €0.105 | +0.005 | +4.8% | €0.103 | €0.136 | €0.103 | 12,045,184 | |
| €0.100 | +0.001 | +1.4% | €0.100 | €0.108 | €0.100 | 931,452 | |
| €0.099 | -0.011 | -9.9% | €0.104 | €0.110 | €0.099 | 594,666 | |
| €0.110 | +0.002 | +2.0% | €0.102 | €0.110 | €0.097 | 2,111,581 | |
| €0.107 | -0.005 | -4.1% | €0.112 | €0.116 | €0.106 | 1,687,018 | |
| €0.112 | -0.007 | -5.9% | €0.115 | €0.118 | €0.112 | 1,250,475 | |
| €0.119 | -0.001 | -1.0% | €0.123 | €0.123 | €0.117 | 859,136 | |
| €0.120 | -0.005 | -3.8% | €0.124 | €0.129 | €0.116 | 1,771,842 | |
| €0.125 | +0.013 | +11.6% | €0.114 | €0.149 | €0.112 | 8,238,590 | |
| €0.112 | -0.008 | -6.7% | €0.119 | €0.130 | €0.106 | 3,936,482 | |
| €0.120 | -0.006 | -4.8% | €0.115 | €0.124 | €0.114 | 3,747,290 | |
| €0.126 | -0.011 | -8.0% | €0.137 | €0.137 | €0.122 | 3,258,766 | |
| €0.137 | -0.009 | -6.2% | €0.150 | €0.159 | €0.133 | 4,372,436 | |
| €0.146 | +0.004 | +3.0% | €0.138 | €0.158 | €0.126 | 8,096,698 | |
| €0.142 | -0.022 | -13.3% | €0.153 | €0.159 | €0.135 | 9,721,200 | |
| €0.164 | +0.034 | +25.8% | €0.130 | €0.175 | €0.130 | 22,148,908 | |
| €0.130 | -0.026 | -16.7% | €0.160 | €0.165 | €0.122 | 11,478,540 | |
| €0.156 | +0.067 | +74.9% | €0.101 | €0.161 | €0.101 | 28,520,221 | |
| €0.089 | +0.001 | +1.6% | €0.090 | €0.095 | €0.085 | 1,210,755 | |
| €0.088 | -0.013 | -13.1% | €0.105 | €0.109 | €0.085 | 2,230,384 | |
| €0.101 | +0.022 | +27.8% | €0.080 | €0.115 | €0.077 | 6,705,725 | |
| €0.079 | +0.003 | +3.9% | €0.080 | €0.082 | €0.075 | 586,071 | |
| €0.076 | +0.012 | +18.7% | €0.067 | €0.087 | €0.064 | 2,618,690 |
Splits
2 splits since 2022 · EURONEXT:ALTME · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 107-for-97 | Split | |
| 1-for-100 | Consolidation |
- Ticker
- Lang & Schwarz:A3DMC3
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Nov 10, 2026
TME Pharma provides further details on the exclusive negotiation agreement with TMS Co., Ltd. for NOX-A12
Latest news
TME Pharma provides further details on the exclusive negotiation agreement with TMS Co., Ltd. for NOX-A12
Nov 10, 2026
Closed €0.106 (-2.9%) on Nov 10, 2026
GLORIA Study Team Receives the 2026 German University Medicine Prize for Its Glioblastoma Research with CXCL12 Inhibitor NOX-A12
Nov 3, 2026
Closed €0.114 (-0.3%) on Nov 3, 2026
TME Pharma Publishes Its Semi Annual Results and Half-Year Report
Oct 30, 2026
Closed €0.124 (-11.3%) on Oct 30, 2026
TME Pharma Signs Binding Exclusive Negotiation Agreement with Japanese TMS Co., Ltd.
Oct 29, 2026
Closed €0.14 (+16.5%) on Oct 29, 2026
TME Pharma extends financial visibility by lengthening debt maturity to June 2028
Oct 26, 2026
Closed €0.116 (-6.1%) on Oct 26, 2026
TME Pharma CEO message
Sep 16, 2026
Closed €0.105 (+4.8%) on Sep 16, 2026
Message du CEO de TME Pharma
Sep 15, 2026
Closed €0.105 (+4.8%) on Sep 16, 2026
TME Pharma fait le point sur ses activités
Aug 23, 2026
Closed €0.156 (+74.9%) on Aug 24, 2026
Minutes of the TME Pharma Annual General Meeting
Jun 17, 2026
Closed €0.077 (+0.9%) on Jun 18, 2026
Compte-rendu de l’assemblée générale de TME Pharma
Jun 16, 2026
Closed €0.076 (-3.4%) on Jun 17, 2026
Financings
Bonds
Nov 17, 2025 · US$1.94M
Terms changed: €1.71M · Warrants at €0.1 for 24 months
Buyers: D.M. van den Ouden (29% of the new bond issue); Mr. van den Ouden (will be issued 4,980,000 warrants to subscribe for up to 4,980,000 common shares); Diede van den Ouden (CEO; with 2 Supervisory Board members holds 29% of the May and August 2025 bonds); Maurizio PetitBon (50,000.00 € debt cash purchase amount); Lee Schalop (20,000.00 € debt cash purchase amount)
Insiders: Holders who agreed in principle to a one-year extension are CEO Diede van den Ouden and 2 Supervisory Board members, holding 29% of the May and August 2025 bonds (face value €718,946)
Use of proceeds: Support ongoing operations while seeking partners to advance the NOX-A12 and NOX-E36 clinical programs
Announced May 21, 2025 · Update May 26, 2025 · Update May 27, 2025 · Terms changed Nov 17, 2025
Bonds
Nov 17, 2025 · US$584,413
Closed: €500,000 raised · Warrants at €0.11 for 21 months
Buyers: Diede van den Ouden (CEO; with 2 Supervisory Board members holds 29% of the May and August 2025 bonds); Maurizio PetitBon (50,044.00 € subscription price; 639,272 warrants)
Insiders: Holders who agreed in principle to a one-year extension are CEO Diede van den Ouden and 2 Supervisory Board members, holding 29% of the May and August 2025 bonds (face value €718,946)
Use of proceeds: R&D, treasury investment strategy and search for acquisitions and partnerships in profitable businesses
Announced Aug 25, 2025 · Closed Sep 1, 2025 · Terms changed Nov 17, 2025
Warrant exercise of new ordinary shares from exercise of Warrants Z
Jun 27, 2025
Closed: €249,396 raised · €0.2 a share
Decks
Investor Presentation (June 2025)
Investor deck · 48 slides · June 2025
Shareholder Meeting (June 2024)
Shareholder meeting · 36 slides · Jun 27, 2024
Investor Presentation (December 2023)
Investor deck · 45 slides · December 2023
Corporate Update (November 2023)
Corporate update · 16 slides · Nov 30, 2023
TME Pharma N.V. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 15 in the last 12 months · 34 in all · newest Nov 10, 2026 · oldest 2025
- Decks
- 14 decks · latest June 2025
Where TME Pharma N.V. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:ALTME · Home listing | Euronext | France | EUR |
| gettex:0N6A | gettex | Germany | EUR |
| LS Exchange:A3DMC3 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A3DMC3 · This page | Lang & Schwarz | Germany | EUR |
| Turquoise:ALTMEP | Turquoise | United Kingdom | EUR |
| Dusseldorf:0N6A | Dusseldorf | Germany | EUR |
| Frankfurt:0N6A | Frankfurt | Germany | EUR |
| Hamburg:0N6A | Hamburg | Germany | EUR |
| Munich:0N6A | Munich | Germany | EUR |
| Stuttgart:0N6A | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about TME Pharma N.V.